SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kabra Drugs informs about outcome of AGM

30 Sep 2024 Evaluate
Kabra Drugs has informed that as on the 35th Annual General Meeting of the Company held on Monday, 30th September 2024 at 10.00 am at registered office of the company and meeting ended at 10.30 am, transacted the following business - Approved the financial statement for the year ended 31st March 2024, together with Auditors' Report and Directors' Report; Bangalore Venkata Krishnappa Ananthkumar (Din No. 08644948) was re-appointed as Director of the company in 35th Annual General Meeting held on 30th September, 2024; appointed PPN And Company Chartered Accountants, (FRN:013623S) as Statutory Auditors and fixed their Remuneration for an initial term of 5 years; approved to shift registered office of the Company from 208, Swadesh Bhavan, 2 Press Complex, AB Road, Indore, Madhya Pradesh - 452011. to Kabra Drugs Ltd, No: 3, 2nd Floor, Swaminathan Street, West Mambalam, Chennai - 600 033; Approved the re-appointment of B V Anatha Kumar (Din:08644948) as the WholeTime Director of the Company for a term of 2 years; Approved the regularization of N. Aravind (Din: 01895602) as Managing Director on The Board of the Company; pproved the change in designation of Kuniamuthur Nanjappan Anand (Din: 03230186) as the Executive Director of the Company. The Company has received a request from the below-mentioned shareholder for issuance of Duplicate Share Certificates consequent to loss of original Share Certificates. The details of lost certificates are enclosed.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

27.45 0.62 (2.31%)
22-Apr-2026 09:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.30
Dr. Reddys Lab 1216.20
Cipla 1230.10
Zydus Lifesciences 927.00
Lupin 2306.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×